Differential Mobilization of Subsets of Progenitor Cells from the Bone Marrow

Cell Stem Cell

Volumn 4, Issue 1, 2009, Pages 62-72

  Pitchford, Simon C ^a   Furze, Rebecca C ^a   Jones, Carla P ^a   Wengner, Antje M ^a   Rankin, Sara M ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

STEMCELL

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR4 ANTAGONIST; GRANULOCYTE COLONY STIMULATING FACTOR; PLERIXAFOR; STROMAL CELL DERIVED FACTOR 1ALPHA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CYCLE REGULATION; CELL MIGRATION; CELL PROLIFERATION; CELL SUBPOPULATION; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIUM CELL; FEMALE; HEMATOPOIETIC STEM CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL MOBILIZATION; STROMA CELL;

ANIMALS; BONE MARROW CELLS; CELL CYCLE; CELL SHAPE; CHEMOKINE CXCL12; CHEMOTAXIS; CYTOKINES; ERYTHROID PRECURSOR CELLS; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HETEROCYCLIC COMPOUNDS; MICE; MICE, INBRED BALB C; NEUTROPHILS; RECEPTORS, CXCR4; STROMAL CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

MUS;

EID: 58049202227     PISSN: 19345909     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.stem.2008.10.017     Document Type: Article

References (43)

1. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., Witzenbichler B., Schatteman G., and Isner J.M. Isolation of putatative progenitor endothelial cells for angiogenesis. Science 275 (1997) 964-967
2. Bielby R., Jones E., and McGonagle D. The role of mesenchymal stem cells in maintenance and repair of bone. Injury 38 (2007) S26-S32
3. Bowie M.B., McKnight K.D., Kent D.G., McCaffrey L., Hoodless P.A., and Eaves C.J. Hematopoietic stem cells proliferate until after birth and show a reversible phase-specific engraftment defect. J. Clin. Invest. 116 (2006) 2808-2816
4. Broxmeyer H.E., Orschell C.M., Clapp D.W., Hangoc G., Cooper S., Plett P.A., Liles W.C., Li X., Graham-Evans B., Campbell T.B., et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J. Exp. Med. 201 (2005) 1307-1318
5. Calandra G., McCarty J., McGuirk J., Tricot G., Crocker S.A., Badel K., Grove B., Dye A., and Bridger G. AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data. Bone Marrow Transplant. 41 (2008) 331-338
6. Cashen A.F., Link D., Devine S., and DiPersio J. Cytokines and stem cell mobilization for autologous and allogeneic transplantation. Curr. Hematol. Rep. 3 (2004) 406-412
7. Capoccia B.J., Shepherd R.M., and Link D.C. G-CSF and AMD3100 mobilize monocytes into the blood that stimulate angiogenesis in vivo through a paracrine fashion. Blood 108 (2006) 2438-2445
8. Colvin G.A., Dooner M.S., Dooner G.J., Sanchez-Guijo F.M., Demers D.A., Abedi M., Ramanathan M., Chung S., Pascual S., and Quesenberry P.J. Stem cell continuum: differentiation hotspots. Exp. Hematol. 35 (2007) 96-107
9. Ellis S.G., Penn M.S., Bolwell B., Garcia M., Chacko M., Wang T., Brezina K.J., McConnell G., and Topol E.J. Granulocyte colony stimulating factor in patients with large acute myocardial infarction: Results of a pilot dose-escalation randomized trial. Am. Heart J. 152 (2006) e9-e14
10. Forster R., Kremmer E., Schubel A., Breitfeld D., Kleinschmidt A., Nerl C., Bernhardt G., and Lipp M. Intracellular and surface expression of the HIV-1 coreceptor CXCR4/fusin on various leukocyte subsets: rapid internalization and recycling upon activation. J. Immunol. 160 (1998) 1522-1531
11. Gerber H.-P., McMurtrey A., Kowalski J., Yan M., Keyt B.A., Dixit V., and Ferrara N. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. J. Biol. Chem. 273 (1998) 30336-30343
12. Gerber H.-P., Malik A.K., Solar G.P., Sherman D., Liang X.H., Meng G., Hong K., Marsters J.C., and Ferrara N. VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism. Nature 417 (2002) 954-958
13. Hattori K., Dias S., Heissig B., Hackett N.R., Lyden D., Tateno M., Hicklin D.J., Zhu Z., Witte L., Crystal R.G., et al. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J. Exp. Med. 193 (2001) 1005-1014
14. Hattori K., Heissig B., Wu Y., Dias S., Tejada R., Ferris B., Hicklin D.J., Zhu Z., Bohlen P., Witte L., et al. Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment. Nat. Med. 8 (2002) 841-849
15. Hess D.C., and Borlongan C.V. Stem cells and neurological diseases. Cell Prolif. 41 Suppl 1 (2008) 94-114
16. Hill J.M., Syed M.A., Arai A.E., Powell T.M., Paul J.D., Zalos G., Read E.J., Khuu H.M., Leitman S.F., Horne M., et al. Outcomes and risks of granulocyte colony-stimulating factor in patients with coronary artery disease. J. Am. Coll. Cardiol. 46 (2005) 1643-1648
17. Ince H., Petzsch M., Kleine H.D., Schmidt H., Rehders T., Körber T., Schümichen C., Freund M., and Nienaber C.A. Preservation from left ventricular remodelling by front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction using granulocyte-colony-stimulating factor (FIRSTLINE-AMI). Circulation 112 (2005) 3097-3106
18. Kocker A.A., Schuster M.D., Szabolcs M.J., Takuma S., Burkhoff D., Wang J., Homma S., Edwards N.M., and Itescu S. Neovascularization of ischaemic myocardium by human bone marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodelling and improves cardiac function. Nat. Med. 7 (2001) 430-436
19. Le Blanc K., and Ringden O. Immunomodulation by mesenchymal stem cells and clinical experience. J. Intern. Med. 262 (2007) 509-525
20. Levesque J.P., Hendy J., Takamatsu Y., Simmons P.J., and Bendall L.J. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by G-CSF or cyclophosphamide. J. Clin. Invest. 111 (2003) 187-196
21. Lord B.I., Bronchud M.H., Owens S., Chang J., Howell A., Souza L., and Dexter T.M. The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo. Proc. Natl. Acad. Sci. USA 86 (1989) 9499-9503
22. Martin C., Burdon P.C., Bridger G., Gutierrez-Ramos J.C., Williams T.J., and Rankin S.M. Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence. Immunity 19 (2003) 583-593
23. Martin C., Bridger G.J., and Rankin S.M. Structural analogues of AMD3100 mobilise haematopoietic progenitor cells from bone marrow in vivo according to their ability to inhibit CXCL12 binding to CXCR4 in vitro. Br. J. Haematol. 134 (2006) 326-329
24. Meirelles L.D.S., and Nardi N.B. Murine marrow-derived mesenchymal stem cell: isolation, in vitro expansion, and characterization. Br. J. Haematol. 123 (2003) 703-711
25. Moore M.A., Hattori K., Heissig B., Shieh J.H., Dias S., Crystal R.G., and Rafii S. Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and angiopoietin-1. Ann. N Y Acad. Sci. 938 (2001) 36-45
26. McKinstry W.J., Li C.-L., Rasko J.E.J., Nicola N.A., Johnson G.R., and Metcalf D. Cytokine receptor expression on hematopoietic stem and progenitor cells. Blood 89 (1997) 65-71
27. Nolan D.J., Ciarrocchi A., Mellick A.S., Jaggi J.S., Bambino K., Gupta S., Heikamp E., McDevitt M.R., Scheinberg D.A., Benezra R., and Mittal V. Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization. Genes Dev. 21 (2007) 1546-1558
28. Ohki Y., Heissig B., Sato Y., Akiyama H., Zhu Z., Hicklin D.J., Shimada K., Ogawa H., Daida H., Hattori K., and Ohsaka A. Granulocyte colony-stimulating factor promotes neovascularisation by releasing vascular endothelial growth factor from neutrophils. FASEB J. 19 (2005) 2005-2017
29. Orlic D., Kajstura J., Chimenti S., Jakoniuk I., Anderson S.M., Li B., Pickel J., McKay R., Nadal-Ginard B., Bodine D.M., et al. Bone marrow cells regenerate infarcted myocardium. Nature 410 (2001) 701-705
30. Palframan R.T., Collins P.D., Severs N.J., Rothery S., Williams T.J., and Rankin S.M. Mechanisms of acute eosinophil mobilization from the bone marrow stimulated by interleukin 5: the role of specific adhesion molecules and phosphatidylinositol 3-kinase. J. Exp. Med. 88 (1998) 1621-1632
31. Phinney D.G., Kopen G., Isaacson R.L., and Prockop D.J. Plastic adherent stromal cells from the bone marrow of commonly used strains of inbred mice: variations in yield, growth, and differentiation. J. Cell. Biochem. 72 (1999) 570-585
32. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., and Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
33. Rankin S.M. Impact of bone marrow on respiratory disease. Curr. Opin. Pharmacol. 8 (2008) 1-6
34. Ripa R.S., Jørgensen E., Wang Y., Thune J.J., Nilsson J.C., Søndergaard L., Johnsen H.E., Køber L., Grande P., and Kastrup J. Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial. Circulation 113 (2006) 1983-1992
35. Roberts A.W., and Metcalf D. Noncycling status of peripheral blood progenitor cells mobilized by granulocyte colony-stimulating factor and other cytokines. Blood 86 (1995) 1600-1605
36. Shepherd R.M., Capoccia B.J., Devine S.M., Dipersio J., Trinkaus K.M., Ingram D., and Link D.C. Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood flowing treatment with AMD3100. Blood 108 (2006) 3662-3667
37. Takahashi T., Kalka C., Masuda H., Chen D., Silver M., Kearney M., Magner M., Isner J.M., and Asahara T. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 5 (1999) 434-438
38. Uchida N., He D., Friera A.M., Reitsma M., Sasaki D., Chen B., and Tsukamoto A. The unexpected G0/G1 cell cycle status of mobilized hematopoietic stem cells from peripheral blood. Blood 89 (1997) 465-472
39. Wengner A.M., Pitchford S.C., Furze R.C., and Rankin S.M. The coordinated action of G-CSF and ELR+ CXC chemokines in neutrophil mobilization during acute inflammation. Blood 111 (2008) 42-49
40. Wilson A., Oser G.M., Jaworski M., Blanco-Bose W.E., Laurenti E., Adolphe C., Essers M.A., Macdonald H.R., and Trumpp A. Dormant and Self-renewing hematopoietic stem cells and their niches. Ann. N Y Acad. Sci. 1106 (2007) 64-75
41. Yoder M.C., Mead L.E., Prater D., Krier T.R., Mroueh K.N., Li F., Krasich R., Temm C.J., Prchal J.T., and Ingram D.A. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109 (2007) 1801-1809
42. Yoon C.-H., Hur J., Park K.W., Kim J.H., Lee C.S., Oh I.Y., Kim T.Y., Cho H.J., Kang H.J., Chae I.H., et al. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells. Circulation 112 (2005) 1618-1627
43. Zohlnhöfer D., Ott I., Mehilli J., Schömig K., Michalk F., Ibrahim T., Meisetschläger G., von Wedel J., Bollwein H., Seyfarth M., et al. Stem cell mobilization by granulocyte-colony stimulating factor in patients with acute myocardial infarction: a randomized controlled trial. JAMA 295 (2006) 1003-1010